HRT Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-704,900
| Closed | -$43M | – | 2334 |
|
|
2025
Q1 | $43M | Sell |
704,900
-899,981
| -56% | -$54.9M | 0.27% | 31 |
|
|
2024
Q4 | $90.8M | Buy |
1,604,881
+1,589,449
| +10,300% | +$89.9M | 0.47% | 18 |
|
|
2024
Q3 | $798K | Buy |
+15,432
| New | +$798K | ﹤0.01% | 1261 |
|
|
2024
Q1 | – | Sell |
-221,739
| Closed | -$11.4M | – | 2227 |
|
|
2023
Q4 | $11.4M | Buy |
+221,739
| New | +$11.4M | 0.08% | 133 |
|
|
2023
Q3 | – | Sell |
-229,452
| Closed | -$14.7M | – | 2195 |
|
|
2023
Q2 | $14.7M | Buy |
+229,452
| New | +$14.7M | 0.14% | 100 |
|
|
2023
Q1 | – | Sell |
-75,662
| Closed | -$5.44M | – | 2330 |
|
|
2022
Q4 | $5.44M | Buy |
+75,662
| New | +$5.44M | 0.08% | 236 |
|
|
2022
Q3 | – | Sell |
-30,539
| Closed | -$2.35M | – | 2630 |
|
|
2022
Q2 | $2.35M | Sell |
30,539
-279,862
| -90% | -$21.5M | 0.03% | 493 |
|
|
2022
Q1 | $22.7M | Buy |
+310,401
| New | +$22.7M | 0.16% | 66 |
|
|
2021
Q3 | – | Sell |
-303,393
| Closed | -$20.3M | – | 3019 |
|
|
2021
Q2 | $20.3M | Buy |
303,393
+70,388
| +30% | +$4.7M | 0.19% | 83 |
|
|
2021
Q1 | $14.7M | Buy |
233,005
+174,274
| +297% | +$11M | 0.15% | 75 |
|
|
2020
Q4 | $3.64M | Buy |
+58,731
| New | +$3.64M | 0.07% | 187 |
|
|
2020
Q3 | – | Sell |
-660,374
| Closed | -$38.8M | – | 1816 |
|
|
2020
Q2 | $38.8M | Buy |
+660,374
| New | +$38.8M | 1.17% | 9 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 673 |
|
|
2015
Q1 | – | Sell |
-3,765
| Closed | -$222K | – | 70 |
|
|
2014
Q4 | $222K | Buy |
+3,765
| New | +$222K | 0.31% | 48 |
|